Used in biomedical research to quantify levels of Plasminogen Activator Inhibitor-1 (PAI-1) in biological samples such as plasma, serum, and cell culture supernatants. It plays a critical role in studying fibrinolysis, the process that breaks down blood clots, and is especially valuable in research related to thrombosis, cardiovascular diseases, and metabolic disorders like obesity and type 2 diabetes. Elevated PAI-1 levels are associated with increased risk of clot formation and insulin resistance, making this kit essential for investigating disease mechanisms and potential therapeutic interventions. Widely used in both academic and pharmaceutical research settings for high-throughput screening and biomarker validation.